Evolent Health, Inc.EVHNYSE
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year operating income growth rate
Latest
175.66%
↑ 121% above average
Average (39q)
-827.37%
Historical baseline
Range
High:379.54%
Low:-30184.91%
CAGR
+6.1%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | 175.66% |
| Q2 2025 | 27.81% |
| Q1 2025 | 91.28% |
| Q4 2024 | -14.31% |
| Q3 2024 | -308.89% |
| Q2 2024 | 158.08% |
| Q1 2024 | 37.19% |
| Q4 2023 | -19.02% |
| Q3 2023 | 16.83% |
| Q2 2023 | -108.29% |
| Q1 2023 | -451.38% |
| Q4 2022 | -114.50% |
| Q3 2022 | 379.54% |
| Q2 2022 | -65.58% |
| Q1 2022 | 77.09% |
| Q4 2021 | -85.59% |
| Q3 2021 | 14.21% |
| Q2 2021 | 51.89% |
| Q1 2021 | -30184.91% |
| Q4 2020 | 100.32% |
| Q3 2020 | 92.72% |
| Q2 2020 | -800.04% |
| Q1 2020 | 88.31% |
| Q4 2019 | -965.62% |
| Q3 2019 | 20.19% |
| Q2 2019 | 45.91% |
| Q1 2019 | -249.36% |
| Q4 2018 | -21.05% |
| Q3 2018 | -23.02% |
| Q2 2018 | 36.56% |
| Q1 2018 | 22.56% |
| Q4 2017 | -30.16% |
| Q3 2017 | 26.66% |
| Q2 2017 | 10.90% |
| Q1 2017 | 36.66% |
| Q4 2016 | -113.86% |
| Q3 2016 | -25.42% |
| Q2 2016 | 92.79% |
| Q1 2016 | -1134.70% |
| Q4 2015 | 17.73% |